<p>Flaten 涉及醫療保健行業，專注於 Achieve Life Sciences、Harrow Health 和 Insight Molecular Diagnostics 等股票。根據 TipRanks，Flaten 推薦股票的平均回報率為 18.0%，成功率為 54.15%。</p>
<p>除了 Lake Street，Biodesix 還在昨天的報告中獲得了 Craig-Hallum 的 William Bonello 的買入評級。然而，今天，William Blair 對 Biodesix (NASDAQ: BDSX) 維持了持有評級。</p>

BDSX

<p>Flaten 涉及醫療保健行業，專注於 Achieve Life Sciences、Harrow Health 和 Insight Molecular Diagnostics 等股票。根據 TipRanks 的數據，Flaten 的平均回報率為 18.0%，推薦股票的成功率為 54.15%。除了 Lake Street，Biodesix 還在昨天的報告中獲得了 Craig-Hallum 的 William Bonello 的買入評級。然而，今天，William Blair 對 Biodesix (NASDAQ: BDSX) 維持了持有評級</p>

<p>Flaten covers the Healthcare sector, focusing on stocks such as Achieve Life Sciences, Harrow Health, and Insight Molecular Diagnostics. According to TipRanks, Flaten has an average return of 18.0% and a 54.15% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Flaten 涉及醫療保健行業，專注於 Achieve Life Sciences、Harrow Health 和 Insight Molecular Diagnostics 等股票。根據 TipRanks，Flaten 推薦股票的平均回報率為 18.0%，成功率為 54.15%。</p>
</div><p>In addition to Lake Street, Biodesix also received a Buy from Craig-Hallum’s William Bonello in a report issued yesterday. However, today, William Blair maintained a Hold rating on Biodesix (NASDAQ: BDSX).</p>
<div class="lb-trans"><p>除了 Lake Street，Biodesix 還在昨天的報告中獲得了 Craig-Hallum 的 William Bonello 的買入評級。然而，今天，William Blair 對 Biodesix (NASDAQ: BDSX) 維持了持有評級。</p>
</div>

Biodesix (BDSX) 獲得了 Lake Street 的買入評級